Sei Investments Co. Sells 139,855 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sei Investments Co. lowered its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 21.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 504,934 shares of the medical instruments supplier's stock after selling 139,855 shares during the period. Sei Investments Co. owned approximately 0.25% of DENTSPLY SIRONA worth $9,584,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Nordea Investment Management AB lifted its position in DENTSPLY SIRONA by 245.0% during the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock worth $4,754,000 after purchasing an additional 178,639 shares during the period. JPMorgan Chase & Co. boosted its position in shares of DENTSPLY SIRONA by 206.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp increased its stake in DENTSPLY SIRONA by 27.9% in the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after acquiring an additional 523,692 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in DENTSPLY SIRONA by 1.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock worth $39,880,000 after purchasing an additional 35,360 shares during the last quarter. Finally, Barclays PLC boosted its holdings in shares of DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock valued at $8,301,000 after purchasing an additional 54,920 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Remove Ads

Insiders Place Their Bets

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.52% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Barrington Research reduced their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Evercore ISI reissued an "in-line" rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. StockNews.com cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Wells Fargo & Company lowered their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. Finally, Morgan Stanley cut their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a report on Tuesday, December 17th. Twelve investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $23.33.

DENTSPLY SIRONA Trading Down 8.4 %

XRAY stock traded down $1.25 during midday trading on Thursday, hitting $13.62. The stock had a trading volume of 4,021,351 shares, compared to its average volume of 2,918,984. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The business has a fifty day moving average price of $17.25 and a two-hundred day moving average price of $19.89. DENTSPLY SIRONA Inc. has a 1-year low of $13.57 and a 1-year high of $33.02. The firm has a market cap of $2.71 billion, a P/E ratio of -6.58, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.70%. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.